Raynaud’s phenomenon in the rheumatologist’s practice

by R.T. Alekperov
Published 2014-05-01

Raynaud’s phenomenon in the rheumatologist’s practice

by R.T. Alekperov
Published 2014-05-01

RAYNAUD’S PHENOMENON: A MULTIDISCIPLINARY PROBLEM

by R. T. Alekperov
Published 2016-02-01

Evaluation of clinical efficacy of prostanoid therapy for Raynaud’s phenomenon in rheumatic diseases

by Z R Bagautdinova, I R Gaisin, M M Glavatskikh, T A Bragina
Published 2018-12-01

Characteristic of microcirculatory changes in patients with primary Raynod's phenomenon by videocapillaroscopy

by T A Nevskaya, N G Guseva
Published 2003-06-01

Therapy for digital ulcers in patients with systemic scleroderma

by M. N. Starovoitova, O. V. Desinova
Published 2019-01-01

Upper extremity neuromotor dysfunction caused by local vibration

by O. A. Shavlovskaya
Published 2015-06-01

Current therapy of interstitial pneumonia associated with systemic scleroderma

by L. P. Ananieva
Published 2020-11-01

Mixed connective tissue disease

by R. U. Shayakhmetova, L. P. Ananyeva
Published 2019-03-01

Efficacy and safety of sildenafil in patients with systemic scleroderma

by R T Alekperov, L P Anan'eva, E G Korzeneva, E O Cheremukhina
Published 2013-05-01

ANALYSIS OF DISEASE MODIFYING DRUGS ADMINISTRATION FREGUENCY AND CAUSES OF THEIR WITHDRAWAL IN RHEUMATOID ARTHRITIS

by E V Pavlova, O M Lesnyak, O F Ryabitseva
Published 2000-02-01

ASSESSMENT OF THE SENSITIVITY OF NEW CRITERIA FOR SYSTEMIC SCLEROSIS IN RUSSIAN PATIENT POPULATION

by O. A. Koneva, O. B. Ovsyannikova, M. N. Starovoitova, E. O. Cheremukhina, E. N. Aleksandrova, L. P. Ananyeva
Published 2015-09-01

CLINICAL EVALUATION OF THE MANIFESTATIONS OF INTERSTITIAL LUNG INJURYIN SYSTEMIC SCLERODERMA FROM HIGH-RESOLUTION COMPUTER T OMOGRAPHY DATA

by L P Anan'eva, L V Teplova, V N Lesnyak, O A Koneva, O B Ovsyannikova, M N Starovoytova, O V Desinova, L P Ananyeva, L V Teplova, V N Lesnyak, O A Koneva, O B Ovsyannikova, M N Starovoitova, O V Desinova
Published 2011-04-01

Traditional cardiovascular risk factors and atherosclerosis in patients with systemic sclerosis

by S. S. Shabanova, L. P. Ananjeva, T. V. Popkova, E. S. Mach, D. S. Novikova, M. N. Starovoytova, L. N. Kashnikova, E. L. Nasonov
Published 2016-05-01

Clinical and laboratory characteristics of patients with systemic sclerosis positive for anti-ribonucleoprotein antibodies

by R. U. Shayakhmetova, L. P. Ananyeva, O. A. Koneva, M. N. Starovoitova, O. V. Desinova, O. B. Ovsyannikova, L. A. Garzanova
Published 2019-11-01

Comparative characteristics of the clinical and laboratory features of the primary Sjogren’s syndrome associated with anticentromere antibodies and the “classic” subtype of the dis...

by B. D. Chaltsev, V. I. Vasiliev, S. G. Palshina, A. V. Torgashina, E. V. Sokol, Yu. I. Khvan, E. B. Rodionova, T. N. Safonova
Published 2021-05-01

CLINICAL AND LABORATORY FEATURES OF ANTICENTROMERE ANTIBODY-POSITIVE SJö GREN’S SYNDROME

by B. D. Chaltsev, V. I. Vasilyev, S. G. Palshina, A. V. Torgashina, E. V. Sokol, Yu. I. Khvan, T. N. Safonova, E. V. Rodionova, I. V. Gaiduk, L. L. Borozdkin
Published 2019-09-01

The relationship between Sjogren’s syndrome, systemic sclerosis and lymphoproliferative diseases

by V. I. Vasil'ev, B. D. Chal'tsev, V. R. Gorodetskii, S. G. Pal'shina, N. S. Shornikova, L. P. Anan'eva, I. V. Gaiduk, N. V. Kokosadze, N. A. Probatova, A. I. Pavlovskaia, E. B. Rodionova, T. N. Safonova, A. A. Balabina
Published 2020-12-01